NCT01306643 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01306643
Title	Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma
Recruitment	Completed
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Gilead Sciences
Indications	non-Hodgkin lymphoma
Therapies	Idelalisib
Age Groups:	adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Stanford Cancer Center		Palo Alto	California	94304-5548	United States	Details
Mount Sinai School of Medicine		New York	New York	10029	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01306643Clinical Trial Detail